We’re proud to be a part of improving patient lives globally with precision health – personalizing diagnoses and treatments in a smarter and more efficient way. In case you missed it, last week GE Healthcare’s Pharmaceutical Diagnostics business (PDx) announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare.
GE released its first quarter 2021 results today, and I encourage you to read the full materials and listen to our earnings call at 8:00 AM ET.
Key highlights on GE’s financial performance this quarter:
For more on GE’s financial performance, click here to subscribe to GE’s investor relations newsletter.
For more on GE’s financial performance, click here to subscribe to GE’s investor relations newsletter.
Fellow investor,
Today GE released its 2020 Annual Report, which includes our Chairman and CEO Larry Culp’s Annual Letter to Shareholders and our 2020 10-K.
For more on GE’s financial performance, click here to subscribe to GE’s investor relations newsletter.
Today GE released its fourth-quarter and full-year results for 2020. You can read the full materials and listen to our earnings call on GE’s investor website. The call will start at 8:00AM ET.
Strong free cash flow finish to a challenging year; momentum growing across GE's businesses
Fourth quarter 2020:
For media inquiries, please contact:
Mary Kate Mullaney
This time of year always presents an opportunity to reflect on the challenges we’ve faced, the progress we’ve made, and how we might improve as we look forward. As I think about the GE story over the course of 2020, I see a team that, despite the challenges of COVID-19, is building momentum.
It’s been an eventful ~6 weeks at GE following our last earnings call. In case you missed it, last week GE Digital CEO and VP of Lean Transformation Pat Byrne joined an investor conference to share how GE is using industrial software and analytics to support our customers. Check out Digital’s webcast and slides here. I also sat down for an investor update with GE Healthcare President and CEO Kieran Murphy.
